Kosj Yamoah is an Oncology physician affiliated with Moffitt Cancer Center. OpenAlex indexes 300 publications with 5,752 citations (h-index 34); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12902 Usf Magnolia Dr
Mcc-Rad Onc
Tampa, FL 336129416
Telephone
888-663-3488Registry record last updated 12 Sept 2016.
Clinical trials
- Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
- PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
- Validation Study on the Impact of Decipher® Testing - VANDAAM Study
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Siemens Medical Solutions USA, Inc.Program year20252 payments
- PFIZER INC.Program year20251 payment
- Ion Beam Applications S.A.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Genitourinary & hormones
100%alpha-Adrenergic Blocker100%Tamsulosin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:
- Ghana IntegRative Approach to Cancer ResEarch Training: The Grace Program
H. Lee Moffitt Cancer Ctr & Res Inst
FY2026$149,096D43CA260649 - Ghana IntegRative Approach to Cancer ResEarch Training: The Grace Program
H. Lee Moffitt Cancer Ctr & Res Inst
FY2026$113,080D43CA260649 - Disrupting the Prostate Tumor Microenvironment in African American Men to Promote Response to Immuno-Modulatory Therapy
H. Lee Moffitt Cancer Ctr & Res Inst
FY2025$668,565R37CA264518
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025
Journal of the National Comprehensive Cancer Network
2025 - Radiation Therapy Summary of the AUA/ASTRO Guideline on Clinically Localized Prostate Cancer
Practical Radiation Oncology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Ignacio Wistuba, MD
Moffitt Cancer Center
Christine Chung, MD
Moffitt Cancer Center
Peter Forsyth, MD
Moffitt Cancer Center
Eric Haura, MD
Moffitt Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”